Brief: Initiator Pharma Q3 Operating Loss DKK 5.2 Million
Nov 10 (Reuters) - Initiator Pharma A/S INIT.ST :
* Q3 OPERATING LOSS DKK 5.2 MILLION VERSUS LOSS DKK 6.7
MILLION
YEAR AGO
Source text for Eikon: ID:nMFNbRhbd8
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD